Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that final positive results from the Phase 2 OPALESCENCE trial[1] of TLX250-CDx (89Zr-girentuximab) in metastatic triple ...

Dr Florian Jaeckle discusses how machine learning models can enhance the speed and accuracy of coeliac disease diagnosis from ...

EMBL scientists have improved a protein analysis technique, significantly expanding its use and making it 100 times faster.

A new method for measuring three different properties of light, at the same time, has been developed using an ...

With the rapid advancements in computer technology and bioinformatics, the prediction of protein-ligand binding sites has ...

We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...

Among people in prison, adding CXR or CRP to symptom screen was more effective than symptom screen alone. In addition to ...